ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Jason A. Williams
Christopher J. Barreiro
Lois U. Nwakanma
Nishant D. Patel
Vincent L. Gott
Michael V. Johnston
William A. Baumgartner
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, J. A.
Right arrow Articles by Baumgartner, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, J. A.
Right arrow Articles by Baumgartner, W. A.
Related Collections
Right arrow Cerebral protection

Ann Thorac Surg 2006;81:2235-2242
© 2006 The Society of Thoracic Surgeons

Original article: Cardiovascular

Valproic Acid Prevents Brain Injury in a Canine Model of Hypothermic Circulatory Arrest: A Promising New Approach to Neuroprotection During Cardiac Surgery

Jason A. Williams, MD a , Christopher J. Barreiro, MD a , Lois U. Nwakanma, MD a , Mary S. Lange, MA b , Lisa E. Kratz, PhD b , Mary E. Blue, PhD b , Jennifer Berrong, BA b , Nishant D. Patel, BA a , Vincent L. Gott, MD a , Juan C. Troncoso, MD b , c , Michael V. Johnston, MD b , William A. Baumgartner, MD a , *

a Division of Cardiac Surgery, The Johns Hopkins Medical Institutions and the Kennedy-Krieger Institute, Baltimore, Maryland
b Department of Neurology, The Johns Hopkins Medical Institutions and the Kennedy-Krieger Institute, Baltimore, Maryland
c Division of Neuropathology, The Johns Hopkins Medical Institutions and the Kennedy-Krieger Institute, Baltimore, Maryland

Accepted for publication December 20, 2005.

* Address correspondence to Dr Baumgartner, Division of Cardiac Surgery, The Johns Hopkins Hospital, 600 N Wolfe St, Blalock 618, Baltimore, MD 21287; (Email: wbaumgar{at}csurg.jhmi.jhu.edu).

Presented at the Forty-second Annual Meeting of The Society of Thoracic Surgeons, Chicago, IL, Jan 30–Feb 1, 2006.

BACKGROUND: The anticonvulsant valproic acid (sodium valproate, DepaconTM) acts as a neuroprotectant in rodents, but has never been tested in larger animals. We used valproate in our canine model of hypothermic circulatory arrest to evaluate its neuroprotective benefit in complex cardiac surgical cases.

METHODS: Thirteen dogs pretreated with valproate before 2 hours of hypothermic circulatory arrest survived for 24 hours (n = 7) or 72 hours (n = 6). Thirteen control animals (placebo only) also survived for 24 hours (n = 7) or 72 hours (n = 6) after hypothermic circulatory arrest. Blinded clinical neurologic evaluation was performed daily until sacrifice using the Pittsburgh Canine Neurologic Scoring System. Brains were harvested for blinded histopathologic analysis by a neuropathologist to determine the extent of apoptosis and necrosis in 11 brain regions (Total Brain Cell Death Score: 0 = normal, 99 = extensive neuronal death in all regions). Quantification of N-acetyl-aspartate, an established marker for brain injury, was performed with mass spectrometry.

RESULTS: Valproate dogs scored significantly better than control animals on clinical neurologic evaluation. Histopathologic examination revealed that valproate animals demonstrated less neuronal damage (by Total Brain Cell Death Score) than control animals at both 24 hours (16.4 versus 11.4; p = 0.03) and 72 hours (21.7 versus 17.7; p = 0.07). At 72 hours, the entorhinal cortex, an area involved with learning and memory, was significantly protected in valproate dogs (p < 0.05). Furthermore, the cortex, hippocampus, and cerebellum demonstrated preservation of near-normal N-acetyl-aspartate levels after valproate pretreatment.

CONCLUSIONS: These data demonstrate clinical, histologic, and biochemical improvements in dogs pretreated with valproate before hypothermic circulatory arrest. This commonly used drug may offer a promising new approach to neuroprotection during cardiac surgery.




This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
J. P. Veinot and M. Ruel
Valproic Acid and Bleeding: Caution Required
Ann. Thorac. Surg., February 1, 2007; 83(2): 725 - 725.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. A. Williams and W. A. Baumgartner
Reply
Ann. Thorac. Surg., February 1, 2007; 83(2): 725 - 726.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 by The Society of Thoracic Surgeons.